WHOCC
Postal address:
WHO Collaborating Centre for Drug Statistics Methodology
Norwegian Institute of Public Health
Postboks 222 Sk°yen
0213 Oslo
Norway

Visiting/delivery address:
Sandakerveien 24C
Bygg C
0473 Oslo
Norway

Tel:  +47 21 07 81 60
E-mail:
 
Copyright/Disclaimer

New search    Hide text from Guidelines

B BLOOD AND BLOOD FORMING ORGANS
B02 ANTIHEMORRHAGICS
B02A ANTIFIBRINOLYTICS

This group comprises agents, which inhibit fibrinolytic activity.

Combinations with vitamin K, see B02B - Vitamin K and other hemostatics.

The DDDs are based on treatment of hemorrhage associated with fibrinolysis.


B02AB Proteinase inhibitors

Combinations with aprotinin used as local hemostatics are classified in B02BC30.


List of abbreviations

Last updated: 2017-12-20